Dana Farber Harvard Cancer Center Consortium — Boston, Massachusetts

Dana Farber Harvard Cancer Center Consortium is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Dana Farber Harvard Cancer Center Consortium has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: NSCLC.

Sponsors: Regeneron Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber Harvard Cancer Center Consortium?

Dana Farber Harvard Cancer Center Consortium has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber Harvard Cancer Center Consortium conducted?

Dana Farber Harvard Cancer Center Consortium has 1 clinical trials on record, with 1 currently active. Their work covers NSCLC.

Is Dana Farber Harvard Cancer Center Consortium accredited by Crixeo Health?

Dana Farber Harvard Cancer Center Consortium has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana Farber Harvard Cancer Center Consortium?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.